The peptide dissolves readily in bacteriostatic water without needing the osmolality adjustment that saline provides
Studies into the molecular mechanisms underlying the time of day differences post ischemia revealed that ischemic/reperfusion injury at ZT 18 had reduced infarct volume, edema, neurological deficits, apoptotic death, and improved neuronal survival compared to other time points (ZT0, ZT6, ZT12, and ZT18), coinciding with a decrease in PRAS40 and increased expression of Bmal1, Per1, Clock, AKT, Erk-1/2, mTOR, S6 , and BAD (Beker et al., 2018)
Clinical trials illustrate this risk
Pharmacological interventions The exploration of pharmacological interventions for the treatment of ME/CFS reveals both potential benefits and risks, particularly concerning gut health [7]